Fol. Biol. 2016, 62, 207-211
https://doi.org/10.14712/fb2016062050207
Apoptosis in Endomyocardial Biopsies from Patients with Dilated Cardiomyopathy
References
1. 2001) Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? – An endomyocardial biopsy study. Cardiovasc. Pathol. 10, 229-234.
< , P., Jobmann, M., Meyer, E., Pankuweit, S., Maisch, B. (https://doi.org/10.1016/S1054-8807(01)00077-1>
2. Barnett, V., Lewis, T., Rothamsted, V. (1994) Outliers in Statistical Data. Wiley Series in Probability and Mathematical Statistics. John Wiley & Sons Ltd, Chichester, New York.
3. 1997) Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Am. J. Pathol. 151, 1205-1213.
, Z., Saikumar, P., Weinberg, J. M., Venkatachalam, M. A. (
4. 2011) Cellular mechanisms of cardiomyopathy. J. Cell. Biol. 194, 355-365.
< , P. A., Leinwand, L. A. (https://doi.org/10.1083/jcb.201101100>
5. 2003) Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon? J. Pathol. 201, 181-186.
< , S. E. (https://doi.org/10.1002/path.1447>
6. 1998) Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. USA 21, 8801-8805.
< , J., Leri, A., Finato, N., Di Loreto, C., Beltrami, C. A., Anversa, P. (https://doi.org/10.1073/pnas.95.15.8801>
7. 1999) Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 99, 2757-2764.
< , M., Takemura, G., Misao, J., Hayakawa, Y., Aoyama, T., Nishigaki, K., Noda, T., Fujiwara, T., Fukuda, K., Maintoguchi, S., Fujiwara, H. (https://doi.org/10.1161/01.CIR.99.21.2757>
8. 1996) Biotin- or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am. J. Pathol. 148, 1771-1777.
, M. M., Muhring, J., Bortier, H., De Meyer, G. R., Jacob, W. (
9. 2003) Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure. J. Pathol. 199, 229-236.
< , M., Takemura, G., Kanoh, M, Hayakawa, K., Kawase, Y., Maruyama, R., Li, Y., Minatoguchi, S., Fujiwara, T., Fujiwara, H. (https://doi.org/10.1002/path.1261>
10. 2002) Apoptosis in myocardial ischaemia and infarction. J. Clin. Pathol. 55, 801-811.
< , P. A. J., Nijmeijer, R., Meijer, C. J. L. M., Visser, C. A., Hack, C. E., Niessen, H. W. M. (https://doi.org/10.1136/jcp.55.11.801>
11. 1995) Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol. 146, 3-15.
, G., Joris, I. (
12. 2001) Age and gender effects on cardiomyocyte apoptosis in the normal human heart. J. Gerontol. Med. Sci. 56A, M719-M723.
< , Z., Fornes, P., Costagliola, R., Esposito, B., Belmin, J., Lecomte, D., Tedgui, A. (https://doi.org/10.1093/gerona/56.11.M719>
13. 1996) Apoptosis in myocytes in endstage heart failure. N. Engl. J. Med. 335, 1182-1189.
< , J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., Khaw, B. A. (https://doi.org/10.1056/NEJM199610173351603>
14. 2005) Myocardial apoptotic index based on in situ DNA nick end-labeling of endomyocardial biopsies does not predict prognosis of dilated cardiomyopathy. Chest 128, 1060-1062.
< , H., Takemura, G., Koda, M., Kanoh, M., Kawase, Y., Minatoguchi, S., Fujiwara, H. (https://doi.org/10.1378/chest.128.2.1060>
15. 1997) Apoptosis in the failig human heart. N. Engl. J. Med. 336, 1131-1141.
< , G., Rakesh, A., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., Reed, J. C., Anversa, P. (https://doi.org/10.1056/NEJM199704173361603>
16. 1993) DNA fragmentation during apoptosis is caused by frequent single-strand cuts. Nucleic Acids Res. 21, 4204-4209.
, M. C., Müller, C., Tschopp, J. (
17. 1996) Report of the World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 93, 841-842.
, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O’Connell, J., Olsen, E., Thiene, G., Goodwin, J., Gyarfas, I., Martin, I., Nordet, P. (
18. 1999) The role of apoptosis in dilated cardiomyopathy. Herz 24, 219-224.
< , J., Lorenz-Meyer, S., Suzuki, K. (https://doi.org/10.1007/BF03044964>
19. 1998) False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate. Mod. Pathol. 51, 204-208.
, B. J., Marti, U., Solioz, M., Zimmermann, H., Reichen, J. (
20. 1998) Effects of prefixation times on apoptosis detection by in situ end-labeling of fragmented DNA. Arch. Pathol. Lab. Med. 122, 252-255.
, H., Tada, T., Hattori, H., Murase, T., Li, W.X., Eimoto, T. (
21. 1998) In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am. J. Pathol. 152, 479-484.
, M., Calabrese, F., Thiene, G., Angelini, A., Basso, C., Nava, A., Rossi, L. (
22. Vasiljević, J. D., Mirić, M. (1995). Viral Myocarditis and Dilated Cardiomyopathy. Tersit, Belgrade. (in Serbian)
23. 2010) Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. Ann. Intern. Med. 152, 513-520, W181.
< , L., Seidman, J. G., Seidman, C. E. (https://doi.org/10.7326/0003-4819-152-8-201004200-00008>
24. 2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 11, 1497-1504.
< , D., Chandra, M., Nguyen, K., Miao, W., Garantziotis, S., Factor, S. M., Shirani, J., Armstrong, R. C., Kitsis, R. N. (https://doi.org/10.1172/JCI17664>
25. 2003) Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy. Cardiovasc. Pathol. 12, 36-39.
< , M., Vraspir-Porenta, O., Zorc-Pleskovič, R., Radovanović, N., Petrovič, D. (https://doi.org/10.1016/S1054-8807(02)00134-5>